Treat osteoporosis in older adults with anti-resorptive and anabolic therapies to reduce fracture risk
Drugs & Therapy Perspectives · 09.07.2026 · 42 (2) · 308-312
DOI: 10.1007/s40267-026-01263-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drugs & Therapy Perspectives, online erschienen am 09.07.2026. Verfasst von Kimberley Chen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Osteoporosis is a progressive skeletal disease involving bone tissue deterioration and a loss in bone mass. Primary osteoporosis affects older adults > 70 years of age and is characterised by a sustained decline in bone mineral density and an increase in fracture risk. Pharmacological treatment comprises of anti-resorptive agents as first line therapy and anabolic agents for patients at very high fracture risk, used either individually or in sequential treatment. Non-pharmacological interventions to manage osteoporosis include calcium and vitamin D supplementation, lifestyle modifications, fall prevention strategies and structured exercise programmes.
Zitieren
APA
Chen, K. (2026). Treat osteoporosis in older adults with anti-resorptive and anabolic therapies to reduce fracture risk. Drugs & Therapy Perspectives, 42(2), 308-312. https://doi.org/10.1007/s40267-026-01263-8
Vancouver
Chen K. Treat osteoporosis in older adults with anti-resorptive and anabolic therapies to reduce fracture risk. Drugs & Therapy Perspectives. 2026;42(2):308-312. doi:10.1007/s40267-026-01263-8
BibTeX
@article{Chen2026,
author = {Chen, Kimberley},
title = {Treat osteoporosis in older adults with anti-resorptive and anabolic therapies to reduce fracture risk},
journal = {Drugs & Therapy Perspectives},
year = {2026},
volume = {42},
number = {2},
pages = {308--312},
doi = {10.1007/s40267-026-01263-8}
}
EUVIMED